# OpenEvidence — Healthcare Investment Intelligence

> ai_healthcare · Series C+. MedFuel Intel profile as of 2026-06-12.

OpenEvidence is an AI-powered clinical decision support platform that analyzes peer-reviewed medical literature to assist physicians at the point of care.[2] As of July 2025, the company raised $210 million in funding led by GV and Kleiner Perkins, valuing it at $3.5 billion, and serves over 430,000 registered U.S. physicians (approximately 40% of all U.S. physicians).[2]

## Key facts (as of 2026-06-12)
- Sector: ai_healthcare
- Stage: Series C+
- Website: https://www.openevidence.com/

## MedFuel assessment
- Intelligence score: 0/100
- Analyses: 0
- Sentiment trend: stable

---
Source: MedFuel Intel — https://medfuelintel.com/company/openevidence-1. Figures reflect MedFuel's analysis; verify against primary sources (SEC, FDA, ClinicalTrials.gov) before any investment decision.